Cardiac Function in an African Dialysis Population with a Low Prevalence of Pre-Existing Cardiovascular Disease

REFERENCES

• Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. Jan, 1995; 47(1)186–192
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. Nov, 1998; 54(5)1720–1725
   PubMedGoogle Scholar
• Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. Jul, 1999; 10(7)1606–1615
   PubMed Web of Science ®Google Scholar
• Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. Aug, 1989; 36(2)286–290
   PubMed Web of Science ®Google Scholar
• Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis. Oct, 2001; 38(4 Suppl. 1)S26–S29
   PubMed Web of Science ®Google Scholar
• Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. Mar, 1995; 47(3)884–890
   PubMed Web of Science ®Google Scholar
• Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol. May, 2008; 3(3)920–929
   PubMedGoogle Scholar
• Locatelli F, Covic A, Chazot C, Leunissen K, Luno J, Yaqoob M. Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant. May, 2004; 19(5)1058–1068
   PubMedGoogle Scholar
• Hase H, Joki N, Ishikawa H, et al. Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients. Ther Apher Dial. Aug, 2006; 10(4)321–327
   PubMedGoogle Scholar
• Hase H, Tsunoda T, Tanaka Y, et al. Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int. Sep, 2006; 70(6)1142–1148
   PubMedGoogle Scholar
• Kessler M, Zannad F, Lehert P, et al. Predictors of cardiovascular events in patients with end-stage renal disease: An analysis from the Fosinopril in dialysis study. Nephrol Dial Transplant. Dec, 2007; 22(12)3573–3579
   PubMedGoogle Scholar
• Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol. Jul, 2002; 13(7)1918–1927
   PubMed Web of Science ®Google Scholar
• Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol. Jan 15, 2008; 51(2)139–145
   PubMedGoogle Scholar
• Owen WF, Madore F, Brenner BM. An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis. Dec, 1996; 28(6)931–936
   PubMed Web of Science ®Google Scholar
• McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. Jun 11, 2007; 167(11)1122–1129
   PubMedGoogle Scholar
• Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. Jul, 1996; 11(7)1277–1285
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol. May, 2000; 11(5)912–916
   PubMedGoogle Scholar
• Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol. Nov, 2001; 12(11)2411–2417
   PubMed Web of Science ®Google Scholar
• Barnes E, Dutka DP, Khan M, Camici PG, Hall RJ. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol. May, 2002; 282(5)H1603–H1608
   Google Scholar
• Bos WJ, Bruin S, van Olden RW, et al. Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis. May, 2000; 35(5)819–826
   PubMed Web of Science ®Google Scholar
• Covic A, Goldsmith DJ, Panaghiu L, Covic M, Sedor J. Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney Int. Jun, 2000; 57(6)2634–2643
   PubMedGoogle Scholar
• McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. Jan, 2008; 3(1)19–26
   PubMed Web of Science ®Google Scholar
• Selby NM, Fonseca S, Hulme L, Fluck RJ, Taal MW, McIntyre CW. Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int. May–Jun, 2006; 26(3)328–335
   PubMedGoogle Scholar
• Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial. May–Jun, 2007; 20(3)220–228
   PubMed Web of Science ®Google Scholar
• Verbeke F, Van Biesen W, Pletinck A, Van Bortel LM, Vanholder R. Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int. Mar–Apr, 2008; 28(2)142–148
   PubMedGoogle Scholar
• Cooper HA, Braunwald E. Clinical importance of stunned and hibernating myocardium. Coron Artery Dis. Aug, 2001; 12(5)387–392
   PubMedGoogle Scholar
• Vonesh EF, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. Feb, 1999; 10(2)354–365
   PubMedGoogle Scholar
• Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol. Feb, 2003; 14(2)415–424
   PubMed Web of Science ®Google Scholar
• Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int. Sep, 2003; 64(3)1071–1079
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Lingenhel A, Neyer U, et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl. May, 2003, 84: S113–S116
   Google Scholar
• Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study. Lancet. Mar 15, 2008; 371(9616)915–922
   PubMed Web of Science ®Google Scholar
• Katz I. Kidney and kidney related chronic diseases in South Africa and chronic disease intervention program experiences. Adv Chronic Kidney Dis. Jan, 2005; 12(1)14–21
   PubMed Web of Science ®Google Scholar
• Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl. Feb, 2003, 83: S119–S122
   Google Scholar
• Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. May, 1996; 49(5)1428–1434
   PubMedGoogle Scholar
• London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. Dec, 2001; 12(12)2759–2767
   PubMedGoogle Scholar
• Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. Apr, 2004; 15(4)1029–1037
   PubMedGoogle Scholar
• Takeda K, Nakamoto M, Baba M, et al. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol. May, 1998; 49(5)308–312
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. Jun, 1995; 5(12)2024–2031
   PubMedGoogle Scholar
• Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH. Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis. May, 2003; 41(5)1016–1025
   PubMedGoogle Scholar
• de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol. Oct, 2003; 14(10)2421–2427
   PubMedGoogle Scholar
• Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. May, 2001; 12(5)1079–1084
   PubMed Web of Science ®Google Scholar
• Lepira FB, Kayembe PK, ’Buyamba-Kabangu M, JR, Nseka MN. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension. Cardiovasc J S Afr. Jan–Feb, 2006; 17(1)7–11
   PubMedGoogle Scholar
• Skudicky D, Sareli P, Libhaber E, et al. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients: Results of the Baragwanath Trial. Circulation. Feb 19, 2002; 105(7)830–836
   PubMedGoogle Scholar
• De Lima JJ, Sesso R, Abensur H, et al. Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant. 1995; 10(9)1708–1713
   PubMedGoogle Scholar
• Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol. Nov–Dec, 2006; 19(6)783–793
   PubMedGoogle Scholar
• Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. Oct, 2001; 12(10)2131–2138
   PubMed Web of Science ®Google Scholar
• Moon KH, Song IS, Yang WS, et al. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol. Sep–Oct, 2000; 20(5)396–401
   PubMedGoogle Scholar
• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. Jul, 1996; 28(1)53–61
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. May, 1996; 49(5)1379–1385
   PubMedGoogle Scholar
• Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. Mar, 2003; 63(3)793–808
   PubMed Web of Science ®Google Scholar
• Bouchard J, Madore F. Inadequate treatment of congestive heart failure in dialysis patients. Semin Dial. Sep–Oct, 2007; 20(5)383–386
   PubMedGoogle Scholar
• Gowdak LH, Arantes RL, de Paula FJ, Krieger EM, De Lima JJ. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients. Ren Fail. 2007; 29(5)559–565
   PubMedGoogle Scholar
• Roy P, Bouchard J, Amyot R, Madore F. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients. Am J Kidney Dis. Oct, 2006; 48(4)645–651
   PubMedGoogle Scholar
• Cice G, Ferrara L, D'Andrea A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol. May 7, 2003; 41(9)1438–1444
   PubMed Web of Science ®Google Scholar
• Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int. Oct, 2006; 70(7)1318–1324
   PubMed Web of Science ®Google Scholar
• Chung A, Iheonunekwu N, Gilbert DT, Barton EN. Cardiac disease in dialysis patients in a Jamaican hospital: Echocardiographic findings that predict mortality. West Indian Med J. Jun, 2007; 56(3)305–308
   PubMedGoogle Scholar
• Mehrotra R, Kermah D, Fried L, Adler S, Norris K. Racial differences in mortality among those with CKD. J Am Soc Nephrol., 2008 Jul;19(7):1403–1410. E-pub 2008 Apr 2.
   Google Scholar
• Volkova N, McClellan W, Soucie JM, Schoolwerth A. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant. Aug, 2006; 21(8)2202–2209
   PubMedGoogle Scholar
• Young BA, Rudser K, Kestenbaum B, Seliger SL, Andress D, Boyko EJ. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS. Kidney Int. May, 2006; 69(9)1691–1698
   PubMedGoogle Scholar
• Liggett SB, Cresci S, Kelly RJ, et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med. May, 2008; 14(5)510–517
   PubMed Web of Science ®Google Scholar